stockrow
Friday 6 November 2026
Export CORZ’s income statement to Excel — free account
Core Scientific, Inc.
CORZ Technology Software Infrastructure
Core Scientific, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319.0 million, down 37.5% from fiscal 2024.
- Revenue
- +108.8%
- EPS
- −12.7%
- Free cash flow
- −852.1%
- Total debt
- +306.4%
Quarter to June 2026, against a year earlier
11.64
0.26
+2.28%
Follow CORZ
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 4 | 4 |
+8 more TTM periods Free account |
| 79.25% | 42.05% | (50.23%) | (8.37%) | ||
| (38.84%) | (13.69%) | 25.04% | 5.19% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(93.28%) | (226.64%) | 34.01% | 5.29% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(3.67) | (1.44) | (1.43) | (1.11) | |
Free Cash Flow |
(1,194.74) | (465.25) | (457.54) | (352.27) | |
Capital Expenditures |
(1,714.98) | (1,038.42) | (735.79) | (491.26) | |
| Other line items | |||||
Cash ROIC |
(31.32%) | (56.64%) | (111.88%) | (135.59%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
1.93 | 2.62 | 3.87 | 2.86 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
130.00 | 270.84 | 163.73 | 248.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
47.44% | 54.06% | 0.00% | 56.04% | |
Share Based Compensation of Revenue |
21.32% | 28.14% | 30.79% | 28.21% | |
Interest Coverage |
(22.16) | (138.27) | — | — | |
Operating CF/Net income |
(0.38) | (1.83) | 0.58 | 1.79 | |
Depreciation/Fixed assets |
0.05 | 0.06 | 0.07 | 0.09 | |
Capex/Depreciation |
(21.22) | (12.43) | (8.54) | (5.00) | |
Revenue per Share |
1.35 | 1.10 | 1.00 | 1.05 | |
Operating CF per Share |
1.60 | 1.78 | 0.87 | 0.44 | |
Capex per Share |
(5.27) | (3.22) | (2.30) | (1.54) | |
Capex to Sales |
3.89 | 2.93 | 2.31 | 1.47 |
Columns are period end dates · fundamentals updated 26 Oct 2026